MediciNova, Inc. Patent applications |
Patent application number | Title | Published |
20150366847 | COMBINATION OF GERANYLGERANYLACETONE AND IBUDILAST AND METHODS OF USING SAME - The present invention relates generally to methods for treating progressive neurodegenerative diseases, including their progressive forms. In particular, the present invention pertains to methods of treating or preventing progressive neurodegenerative diseases and its associated symptoms by administration of a combination of geranylgeranylacetone (teprenone) and ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine), or pharmaceutically acceptable salts thereof. | 12-24-2015 |
20150322004 | METHOD OF TREATING ADVANCED NON-ALCOHOLIC STEATOHEPATITIS - A compound of Formula (I): | 11-12-2015 |
20150321989 | METHOD OF TREATING IDIOPATHIC PULMONARY FIBROSIS - A compound of Formula (I): | 11-12-2015 |
20150320705 | METHOD OF INHIBITING OR TREATING AMYOTROPHIC LATERAL SCLEROSIS WITH PHENOXYALKYLCARBOXYLIC ACIDS - A compound of Formula (I), or a metabolite thereof, or an ester of the compound of Formula (I) or the metabolite thereof, or a pharmaceutically acceptable salt of each thereof | 11-12-2015 |
20150209314 | METHOD OF TREATING LIVER DISORDERS - A compound of Formula (I): | 07-30-2015 |
20150080471 | METHODS FOR REDUCING TRIGLYCERIDE, TOTAL CHOLESTEROL AND LOW DENSITY LIPOPROTEIN BLOOD LEVELS - A compound of Formula (I): | 03-19-2015 |
20150051191 | TREATMENT OF ALCOHOLISM USING IBUDILAST - Alcoholism, and symptoms and negative effects thereof may be treated using ibudilast or a pharmaceutically acceptable salt thereof. Abstinence from alcohol consumption may be maintained using ibudilast or a pharmaceutically acceptable salt thereof. Withdrawal from alcohol may be facilitated and negative effects thereof reduced by using ibudilast or a pharmaceutically acceptable salt thereof. | 02-19-2015 |
20150031769 | METHODS FOR REDUCING TRIGLYCERIDE, TOTAL CHOLESTEROL AND LOW DENSITY LIPOPROTEIN BLOOD LEVELS - A compound of Formula (I): | 01-29-2015 |
20150011581 | TREATMENT OF PROGRESSIVE NEURODEGENERATIVE DISEASE WITH IBUDILAST - Compositions and methods for treating progressive neurodegenerative diseases, and their associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine). | 01-08-2015 |
20140171463 | TREATMENT OF PROGRESSIVE NEURODEGENERATIVE DISEASE WITH IBUDILAST - Compositions and methods for treating progressive neurodegenerative diseases, and their associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine). | 06-19-2014 |
20140155484 | METHOD OF TREATING LIVER DISORDERS - A compound of Formula (I): | 06-05-2014 |
20140128473 | METHOD OF TREATING NON-ALCOHOLIC STEATOHEPATITIS - A compound of Formula (I): | 05-08-2014 |
20140066513 | METHODS FOR COMPOSITIONS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME - A method for a prevention and/or treatment of irritable bowel syndrome or amelioration of a symptom thereof in a subject, comprises administering to said subject an effective amount of a compound of formula I: | 03-06-2014 |
20140056999 | TREATMENT OF ACUTE EXACERBATION OF ASTHMA AND REDUCTION OF LIKELIHOOD OF HOSPITALIZATION OF PATIENTS SUFFERING THEREFROM - The invention provides a method of improving one or more clinical outcomes of an individual experiencing an acute respiratory attack. The acute respiratory attack may include acute reversible bronchospasm, severe acute bronchospasm, or acute exacerbation of asthma. The method includes administering to an individual suffering from an acute respiratory attack an effective amount of bedoradrine or a pharmaceutically acceptable salt thereof in combination with a standard of care (SOC) treatment regimen. | 02-27-2014 |
20140045909 | DENIBULIN DI-HYDROCHLORIDE - MN-029 di-hydrochloride (MN-029.2HCl, Formula 2) is a potent vascular targeting agent. | 02-13-2014 |
20130217718 | TREATMENT OF PROGRESSIVE NEURODEGERATIVE DISEASE WITH IBUDILAST - Compositions and methods for treating progressive neurodegenerative diseases, and their associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine). | 08-22-2013 |
20130178495 | IBUDILAST FOR RELIEVING NEGATIVE EFFECTS OF MEDICATION OVERUSE HEADACHE - Certain negative effects of medication overuse headache (MOH) are relieved by administering ibudilast or a pharmaceutically acceptable salt thereof. | 07-11-2013 |
20130158123 | METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND STEATOHEPATITIS - A compound of Formula (I): | 06-20-2013 |
20130041002 | DENIBULIN DI-HYDROCHLORIDE - MN-029 di-hydrochloride (MN-029.2HCl, Formula 2) is a potent vascular targeting agent. | 02-14-2013 |